IREN saw a positive improvement to its Relative Strength (RS) Rating on Monday, with an upgrade from 78 to 88.
Risk Management In The Stock Market: How Much Money To Invest Now
IBD's proprietary rating identifies share price performance with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the last 52 weeks stacks up against all the other stocks in our database.
Decades of market research reveals that the best-performing stocks often have an RS Rating of above 80 in the early stages of their moves.
IREN is not currently showing a potential buy point. See if the stock goes on to build a chart pattern that could kick off a new price move.
Earnings growth rose in the company's latest report from 0% to 38%, but sales fell from 181% to 172%.
IREN earns the No. 13 rank among its peers in the Financial Services-Specialty industry group. X Financial ADR, Jiayin Group ADR and Marex Group are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
